greeksoup/ stock research
Stock research / United States / MDLN / Q2 FY2025

Medline (MDLN) Q2 FY2025 earnings: revenue $6.9 billion

Medline Inc. (MDLN) reported revenue of $6.9 billion for Q2 FY2025, the quarter ended 28 June 2025. Net income was $329 million. The figures are the company's own, from the 10-Q it filed with the SEC on 5 August 2026.

Revenue$6.9 billion
Net income$329 million
Diluted EPSn/a
QuarterQ2 FY2025ended 28 June 2025

The quarter, against the one before and a year earlier

LineQ2 FY2025Q1 FY2025A year earlierChange on the year
Revenue6,8866,644n/an/a
Cost of revenue4,9814,820n/an/a
Gross profit1,9051,824n/an/a
Gross margin27.7%27.5%n/a
Selling, general and administrative1,0731,070n/an/a
Operating income642571n/an/a
Operating margin9.3%8.6%n/a
Interest expense253244n/an/a
Pre-tax income359338n/an/a
Income tax26.016.0n/an/a
Effective tax rate7.2%4.7%n/a
Net income329319n/an/a
Net margin4.8%4.8%n/a
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ2 FY2025Q1 FY2025A year earlierChange on the year
Operating cash flow197682n/an/a
Capital expenditure11098.0n/an/a
Free cash flow87.0584n/an/a
Free cash flow margin1.3%8.8%n/a
Cash from investing-143-92.0n/an/a
Cash from financing-328-9.0n/an/a
Depreciation and amortisation250247n/an/a
Share-based compensation15.019.0n/an/a
Buybacks6.09.0n/an/a

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ2 FY2025Q1 FY2025A year earlierChange on the year
Redeemable equity367368n/an/a
Cash and equivalents584840n/an/a

Questions

What was Medline's revenue in Q2 FY2025?

Medline (MDLN) reported revenue of $6.9 billion for Q2 FY2025, the quarter ended 28 June 2025.

How much did Medline earn in Q2 FY2025?

Net income for Q2 FY2025 was $329 million.

When did Medline report Q2 FY2025 results?

Medline filed its 10-Q for the quarter ended 28 June 2025 with the SEC on 5 August 2026.

Quarterly results, the last 4 quarters

Q1 FY2025Q2 FY2025Q1 FY2026Q2 FY2026
Revenue6,6446,8867,3527,685
Cost of revenue4,8204,9815,5115,470
Gross profit1,8241,9051,8412,215
Gross margin27%28%25%29%
SG&A1,0701,0731,2281,295
Operating income571642422395
Operating margin9%9%6%5%
Interest expense244253165168
Pre-tax income338359291235
Tax rate5%7%18%41%
Net income31932913259.0
Net margin5%5%2%1%
Diluted EPSn/an/a$0.16$0.07
Operating cash flow682197412715
Capital expenditure98.011096.0111
Free cash flow58487.0316604
Buybacks9.06.00.00.0
Filing10-Q10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read moreMoney is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 28 June 2025, filed 5 August 2026: the filing.